Quince Therapeutics, Inc. (QNCX) Non Operating Interest Expenses (2018)
IRulya Therapeutics (QNCX) reported Non Operating Interest Expenses of $957,000 for FY2018.
Powered by 
Analysis
Quince Therapeutics, Inc. (QNCX) Non Operating Interest Expenses (2018) Analysis & Trends
Peer Set
Peer Comparison
API Access
Quince Therapeutics, Inc. Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=QNCX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "QNCX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=QNCX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();